How Much Weight Will You Lose with Ozempic?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and signaling fullness to your brain, reducing hunger and calorie intake. Clinical trials show participants lost 15–22% of body weight over 68 weeks, though results vary widely based on genetics, adherence, and lifestyle factors. Understanding your personal weight loss trajectory requires knowing how your body responds to GLP-1 activation.

Average Semaglutide Weight Loss Results from Clinical Trials

The STEP program, a series of landmark clinical trials, tracked semaglutide's weight loss effects across thousands of participants with obesity. Participants receiving 2.4 mg semaglutide weekly lost an average of 9.2–10.2 kg (20–22 lbs) more than placebo groups over 68 weeks. Higher doses and longer treatment duration correlated with greater cumulative weight loss, with some patients achieving 15–22% total body weight reduction.

Not everyone reaches maximum weight loss at the same rate or magnitude. Approximately 90% of participants achieved at least a 5% weight loss, while 70% lost more than 10% of their starting weight. These variations highlight the importance of individualized treatment monitoring rather than assuming one-size-fits-all outcomes.

Why Semaglutide Weight Loss Varies From Person to Person

Your genetic makeup influences how strongly your GLP-1 receptors respond to semaglutide, directly affecting appetite suppression and metabolic rate. Variants in genes like GLP1R and GIPR control how efficiently your body processes the medication and signal satiety. PlexusDx's Precision Peptide Genetic Test identifies these 14 pathways and 49 peptide-related variants to predict your individual response pattern.

Beyond genetics, baseline metabolic health, starting weight, and lifestyle consistency determine your weight loss trajectory. A 250-pound person typically experiences faster absolute weight loss than a 180-pound person, though percentage-based loss may differ. Dietary adherence, physical activity level, sleep quality, and stress management amplify or reduce semaglutide's effects.

Realistic Monthly Weight Loss Expectations on Semaglutide

Most patients experience gradual weight loss over the first 3–6 months as they titrate to their maintenance dose. Initial weight loss often peaks between months 2 and 4, with an average of 2–4 pounds per month during this window. After 6 months, the rate may plateau or slow, which is normal and reflects your body reaching a new equilibrium with reduced appetite.

Patience matters more than speed with semaglutide therapy. Monthly fluctuations occur due to water retention, hormonal cycles, and digestion timing. Tracking weekly averages rather than daily weight provides a clearer picture of genuine fat loss progress.

How PlexusDx Personalizes Semaglutide Therapy for Your Goals

PlexusDx compounded semaglutide injections start at $149 per month from licensed 503A pharmacies, with no insurance required and HSA/FSA eligibility. Your dose may need to go up as your body adjusts—your price won't. PlexusDx clinicians adjust your treatment plan based on real weight loss response, side effects, and genetic insights rather than generic protocols.

Adding the Precision Peptide Genetic Test ($99 after your first month) identifies whether your GLP-1 pathway sensitivity is high, moderate, or lower-than-average, informing optimal dosing and duration expectations. This data helps your PlexusDx team predict whether semaglutide alone will meet your weight loss goal or whether combining with tirzepatide through GLP-Squared might deliver better results for your unique genetic profile.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight did people lose on semaglutide in real studies?

In the STEP clinical trials, participants on 2.4 mg semaglutide lost 9.2–10.2 kg more than placebo over 68 weeks, with 70% achieving over 10% body weight loss. Results ranged from 15–22% total body weight loss in the highest-responding patients. Individual outcomes depend on genetics, starting weight, and lifestyle adherence.

Can I expect to lose weight every single month on semaglutide?

Most people see consistent monthly weight loss during the first 3–6 months, averaging 2–4 pounds per month. After 6 months, the rate typically slows as your body reaches a new weight set point. Weekly fluctuations are normal due to water retention and digestion; tracking weekly averages reveals true progress.

What if semaglutide alone doesn't give me the weight loss I want?

PlexusDx offers GLP-Squared, a dual-compound injection combining semaglutide and tirzepatide, starting at $249 per month. Tirzepatide activates an additional receptor (GIP) that amplifies weight loss signals, making it effective for patients who plateau on semaglutide alone.

Does PlexusDx compounded semaglutide work the same as brand-name Ozempic?

PlexusDx semaglutide is manufactured by licensed 503A compounding pharmacies under strict quality controls, containing the identical active pharmaceutical ingredient as brand Ozempic. The main difference is cost—PlexusDx starts at $149 per month versus $900–$1,200 for brand Ozempic.

How does genetic testing help predict my semaglutide weight loss results?

PlexusDx's Precision Peptide Genetic Test identifies your variants in GLP1R, GIPR, FTO, and MC4R genes—key regulators of appetite and metabolism.

Related Reading

• Can My Dna Tell Me How Do You Lose Weight
• Can A Dna Test Tell Me How Do You Lose Weight
• Can You Get A Dna Test To See How Do You Lose Weight
• Ozempic For Losing Weight

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.